Pentwater Capital Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Pentwater Capital Management’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-370,000	Closed	-$8.92M	–	214
2014 Q2	$8.92M	Buy	+370,000	New	+$3.86M	0.09%	88

Pentwater Capital Management's IDIX Position: Q3 2014 in Review

Pentwater Capital Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 370,000 shares — an estimated $8.92M sold.

Pentwater Capital Management first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $8.92M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Pentwater Capital Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Pentwater Capital Management sold 370,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $8.92M.
Pentwater Capital Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Pentwater Capital Management's IDENIX PHARMACEUTICALS INC position peaked at $8.92M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Pentwater Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.